HeartFlow Names New General Counsel to Executive Team
REDWOOD CITY, Calif. – Dec. 23, 2014 – HeartFlow Inc., a pioneer in personalized medical technology for cardiovascular disease, has appointed Noemi C. (“Nicky”) Espinosa, as general counsel. Espinosa brings to HeartFlow 30 years of experience as both a business executive and outside counsel, representing medical device, life science and high tech companies.
“Nicky’s extensive experience and understanding of the complexities of healthcare and business make her an ideal addition to the HeartFlow team,” said John H. Stevens, M.D., chairman and CEO of HeartFlow. “Her knowledge of the legal, regulatory and business hurdles both small and large companies face will be extremely valuable as we commercialize our HeartFlow FFRCT® technology.”
Just prior to joining HeartFlow, Espinosa served as vice president of legal operations and assistant general counsel for Intuitive Surgical in Sunnyvale, Calif. She also served as the vice president of intellectual property for Illumina, Inc., in San Diego. Espinosa also spent more than 20 years in private practice as a litigation partner in the Silicon Valley offices of three major national law firms: Brobeck, Phleger & Harrison LLP, Dewey Ballantine LLP, and Dechert LLP. While in private practice, she advised and represented a variety of emerging growth and publicly held life science and technology companies.
Espinosa received her Bachelor of Science degree in chemical engineering from San Jose State University, and a juris doctorate degree from the University of California, Hastings College of the Law.
About HeartFlow Inc.
HeartFlow Inc. is a personalized medical technology company dedicated to transforming the way cardiovascular disease is managed. Committed to improving outcomes, reducing costs and creating a better patient experience, HeartFlow’s goal is to provide healthcare professionals with actionable knowledge about each patient by combining best-in-class, non-invasive healthcare imaging with advanced, computational fluid dynamics technology and the insights of big data. HeartFlow’s non-invasive FFRCT technology helps physicians diagnose coronary artery disease and provides them with information they need to manage each patient. For more information visit www.heartflow.com.